{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T06:48:52Z","timestamp":1769842132373,"version":"3.49.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.ahj.2005.01.041","type":"journal-article","created":{"date-parts":[[2005,11,11]],"date-time":"2005-11-11T07:14:42Z","timestamp":1131693282000},"page":"871-881","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Antidepressant therapy in patients with ischemic heart disease"],"prefix":"10.1016","volume":"150","author":[{"given":"Wei","family":"Jiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan R.T.","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2005.01.041_bib1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1016\/0002-9149(87)90607-2","article-title":"Major depressive disorder in coronary artery disease","volume":"60","author":"Carney","year":"1987","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.01.041_bib2","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0006-3223(03)00587-0","article-title":"Epidemiology of comorbid coronary artery disease and depression","volume":"54","author":"Rudisch","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib3","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1001\/archinte.1989.00390080059014","article-title":"The nature and course of depression following myocardial infarction","volume":"149","author":"Schleifer","year":"1989","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib4","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.1993.03510150053029","article-title":"Depression following myocardial infarction. Impact on 6-month survival","volume":"270","author":"Frasure-Smith","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.01.041_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/00023210-200216020-00004","article-title":"Depression and heart disease\u2014evidence of a link, and its therapeutic implications","volume":"16","author":"Jiang","year":"2002","journal-title":"CNS Drugs"},{"key":"10.1016\/j.ahj.2005.01.041_bib6","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00006842-198811000-00009","article-title":"Major depressive disorder predicts cardiac events in patients with coronary artery disease","volume":"50","author":"Carney","year":"1988","journal-title":"Psychosom Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib7","first-page":"959","article-title":"Affective disorders and survival after acute myocardial infarction. Results from the post-infarction late potential study","volume":"12","author":"Ladwig","year":"1991","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.01.041_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(94)90877-X","article-title":"Post-infarction depression and incomplete recovery 6 months after myocardial infarction","volume":"343","author":"Ladwig","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2005.01.041_bib9","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1161\/01.CIR.91.4.999","article-title":"Depression and 18-month prognosis after myocardial infarction","volume":"91","author":"Frasure-Smith","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.01.041_bib10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0002-9149(96)00380-3","article-title":"Depression and long-term mortality risk in patients with coronary artery disease","volume":"78","author":"Barefoot","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.01.041_bib11","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2190\/0C1C-A63U-V5XQ-1DAL","article-title":"Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive heart failure: a two-years follow-up study","volume":"29","author":"Murberg","year":"1999","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib12","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1053\/euhj.1999.2012","article-title":"Depressive symptoms and lack of social integration in relation to prognosis of CHD in middle-aged women. The Stockholm Female Coronary Risk Study","volume":"21","author":"Horsten","year":"2000","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2005.01.041_bib13","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1001\/archinte.160.9.1354","article-title":"Depression and 1-year prognosis in unstable angina","volume":"160","author":"Lesp\u00e9rance","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib14","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1440-1622.2001.02055.x","article-title":"Preoperative depression and mortality in coronary artery bypass surgery: preliminary findings","volume":"71","author":"Baker","year":"2001","journal-title":"ANZ J Surg"},{"key":"10.1016\/j.ahj.2005.01.041_bib15","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/S0749-0690(05)70033-1","article-title":"Psychosocial considerations in elderly patients with heart failure","volume":"16","author":"Freedland","year":"2000","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0749-0690(05)70032-X","article-title":"Comorbidity in heart failure in the elderly","volume":"16","author":"McGann","year":"2000","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib17","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1001\/archinte.158.13.1422","article-title":"Depression is a risk factor for coronary artery disease in men: the precursors study","volume":"158","author":"Ford","year":"1998","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib18","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1001\/archinte.160.9.1261","article-title":"Depression as an antecedent to heart disease among women and men in the NHANES I study","volume":"160","author":"Ferketich","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1001\/archpsyc.58.3.221","article-title":"Depression and cardiac mortality: results from a community-based longitudinal study","volume":"58","author":"Penninx","year":"2001","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib20","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0006-3223(03)00320-2","article-title":"Treatment of depression in patients with heart disease","volume":"54","author":"Roose","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib21","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archinte.1996.00440050111012","article-title":"Change in depression as a precursor of cardiovascular events. SHEP Cooperative Research Group (Systolic Hypertension in the Elderly)","volume":"156","author":"Wassertheil-Smoller","year":"1996","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib22","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/S0002-9149(98)00077-0","article-title":"Cardiovascular events and mortality in newly and chronically depressed persons >70 years of age","volume":"81","author":"Penninx","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2005.01.041_bib23","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0006-3223(03)00111-2","article-title":"Depression, mortality, and medical morbidity in patients with coronary heart disease","volume":"54","author":"Carney","year":"2003","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0022-3999(99)00085-9","article-title":"Severe depression is associated with markedly reduced heart rate variability in patients with stable coronary heart disease","volume":"48","author":"Stein","year":"2000","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.ahj.2005.01.041_bib25","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1161\/hc4201.097834","article-title":"Depression, heart rate variability, and acute myocardial infarction","volume":"104","author":"Carney","year":"2001","journal-title":"Circulation"},{"issue":"Suppl 8","key":"10.1016\/j.ahj.2005.01.041_bib26","first-page":"12","article-title":"Depression, anxiety, and the cardiovascular system: the cardiologist's perspective","volume":"62","author":"Sheps","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib27","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/S0022-3999(02)00311-2","article-title":"Depression as a risk factor for cardiac mortality and morbidity. A review of potential mechanisms","volume":"53","author":"Carney","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.ahj.2005.01.041_bib28","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0006-3223(01)01347-6","article-title":"Diminished chaos of heart rate time series in patients with major depression","volume":"51","author":"Yeragani","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib29","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0165-0327(99)00202-5","article-title":"Autonomic neurocardiac function in patients with major depression and effects of antidepressive treatment with nefazodone","volume":"62","author":"Agelink","year":"2001","journal-title":"J Affect Disord"},{"key":"10.1016\/j.ahj.2005.01.041_bib30","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1001\/archinte.160.12.1818","article-title":"Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction","volume":"160","author":"Ziegelstein","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib31","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0002-8703(03)00152-2","article-title":"Depression and increased myocardial ischemic activity in patients with ischemic heart disease","volume":"146","author":"Jiang","year":"2003","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2005.01.041_bib32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1053\/scnp.2001.0060277","article-title":"The neuroimmunology of stress and depression","volume":"6","author":"Raison","year":"2001","journal-title":"Semin Clin Neuropsychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0022-3956(03)00054-2","article-title":"Hypothalamo-pituitary-adrenal function in patients with depressive disorders is correlated with baseline cytokine levels, but not with cytokine responses to hydrocortisone","volume":"37","author":"Schuld","year":"2003","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.ahj.2005.01.041_bib34","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1080\/07853890310004075","article-title":"Cytokines, stress and depressive illness: brain-immune interactions","volume":"35","author":"Anisman","year":"2003","journal-title":"Ann Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib35","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0753-3322(01)00156-1","article-title":"Cytokines and depression: an analogic approach","volume":"56","author":"Corcos","year":"2002","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ahj.2005.01.041_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1017\/S1461145702003164","article-title":"Effects of antidepressants on the production of cytokines","volume":"5","author":"Kenis","year":"2002","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1016\/j.ahj.2005.01.041_bib37","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1017\/S0033291702007250","article-title":"Lack of association between depressive symptoms and markers of immune and vascular inflammation in middle-aged men and women","volume":"33","author":"Steptoe","year":"2003","journal-title":"Psychol Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib38","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1055\/s-2003-36684","article-title":"The HPA-axis as a possible link between depression, diabetes mellitus and cognitive dysfunction","volume":"71","author":"Prestele","year":"2003","journal-title":"Fortschr Neurol Psychiatr"},{"key":"10.1016\/j.ahj.2005.01.041_bib39","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/diacare.15.11.1631","article-title":"Depression in adults with diabetes","volume":"15","author":"Lustman","year":"1992","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2005.01.041_bib40","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1001\/jama.279.4.287","article-title":"Comparison of paroxetine and nortriptyline in depressed patients with ischemic heart disease","volume":"279","author":"Roose","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.01.041_bib41","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1176\/ajp.156.7.1024","article-title":"Treatment of major depression with nortriptyline and paroxetine in patients with ischemic heart disease","volume":"156","author":"Nelson","year":"1999","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib42","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1001\/archpsyc.1961.01710120031004","article-title":"An inventory for measuring depression","volume":"4","author":"Beck","year":"1961","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2190\/LYKR-7VHP-YJEM-MKM2","article-title":"Screening for depression in primary care clinics: the CES-D and the BDI","volume":"20","author":"Zich","year":"1990","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib44","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1001\/jama.1993.03510150053029","article-title":"Depression following myocardial infarction: impact on 6-month survival","volume":"270","author":"Frasure-Smith","year":"1993","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.01.041_bib45","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib46","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1300\/J018v05n01_06","article-title":"Use of the CES-D scale with older adults","volume":"5","author":"Radloff","year":"1986","journal-title":"Clin Gerontol"},{"key":"10.1016\/j.ahj.2005.01.041_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0022-3999(96)00216-4","article-title":"International experiences with the hospital anxiety and depression scale: a review of validation data and clinical results","volume":"42","author":"Herrmann","year":"1997","journal-title":"J Psychosom Res"},{"key":"10.1016\/j.ahj.2005.01.041_bib48","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1097\/01.MLR.0000093487.78664.3C","article-title":"The patient health questionnaire-2: validity of a two-item depression screener","volume":"41","author":"Kroenke","year":"2003","journal-title":"Med Care"},{"key":"10.1016\/j.ahj.2005.01.041_bib49","first-page":"348","article-title":"Depression as a manifestation of obstructive sleep apnea: reversal with nasal continuous positive airway pressure","volume":"50","author":"Millman","year":"1989","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib50","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1017\/S1092852900018356","article-title":"Obstructive sleep apnea and depression","volume":"8","author":"Baran","year":"2003","journal-title":"CNS Spectr"},{"key":"10.1016\/j.ahj.2005.01.041_bib51","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0002-9343(00)00302-8","article-title":"Sleep-related breathing disorders and cardiovascular disease","volume":"108","author":"Roux","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib52","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1207\/S15327558IJBM0701_6","article-title":"Surgical treatment of the sleep apnea syndrome reduces associated major depression","volume":"7","author":"Dahlof","year":"2000","journal-title":"Int J Behav Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib53","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/070674378402900503","article-title":"Depression and its treatment in alcoholics: a review","volume":"29","author":"O'Sullivan","year":"1984","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib54","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1161\/01.CIR.103.4.502","article-title":"Cocaine use and the likelihood of nonfatal myocardial infarction and stroke: data from the Third National Health and Nutrition Examination Survey","volume":"103","author":"Qureshi","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.01.041_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/archpsyc.1991.01810250045005","article-title":"Psychiatric diagnoses of treatment-seeking cocaine abusers","volume":"48","author":"Rounsaville","year":"1991","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib56","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/oem.60.7.489","article-title":"Psychosocial conditions on and off the job and psychological ill health: depressive symptoms, impaired psychological wellbeing, heavy consumption of alcohol","volume":"60","author":"Michelsen","year":"2003","journal-title":"Occup Environ Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib57","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.nmd.0000120885.17362.94","article-title":"Poor mental health, depression, and associations with alcohol consumption, harm, and abuse in a national sample of young adults in college","volume":"192","author":"Weitzman","year":"2004","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.ahj.2005.01.041_bib58","doi-asserted-by":"crossref","first-page":"459","DOI":"10.2165\/00002018-199920050-00006","article-title":"Treating depression in patients with ischaemic heart disease. Which agents are best to use and to avoid?","volume":"20","author":"Roose","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.ahj.2005.01.041_bib59","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1056\/NEJM198908103210629","article-title":"Preliminary report: effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1056\/NEJM199207233270403","article-title":"Effect of the antiarrhythmic agent moricizine on survival after myocardial infarction","volume":"327","author":"Cardiac Arrhythmia Suppression Trial II Investigators","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib61","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/hrt.74.6.631","article-title":"Interaction of ischaemia and encainide\/flecainide treatment: a proposed mechanism for the increased mortality in CAST I","volume":"74","author":"Greenberg","year":"1995","journal-title":"Br Heart J"},{"key":"10.1016\/j.ahj.2005.01.041_bib62","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bmj.323.7314.666","article-title":"Antidepressants as risk factor for ischaemic heart disease: case-control study in primary care","volume":"323","author":"Hippisley-Cox","year":"2001","journal-title":"BMJ"},{"issue":"Suppl 5","key":"10.1016\/j.ahj.2005.01.041_bib63","first-page":"46","article-title":"Consensus statement on depression in the elderly","volume":"2","author":"Montgomery","year":"2000","journal-title":"Prim Care Companion J Clin Psychiat"},{"key":"10.1016\/j.ahj.2005.01.041_bib64","first-page":"23","article-title":"The use of citalopram in patients with cardiovascular disease","volume":"8","author":"Heydorn","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00004714-199910000-00004","article-title":"Cardiac safety of citalopram: prospective trials and retrospective analyses","volume":"19","author":"Rasmussen","year":"1999","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.ahj.2005.01.041_bib66","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1176\/ajp.155.5.660","article-title":"Cardiovascular effects of fluoxetine in depressed patients with heart disease","volume":"155","author":"Roose","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib67","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1097\/00006842-200011000-00007","article-title":"Efficacy and safety of fluoxetine in the treatment of patients with major depression after first myocardial infarction: findings from a double-blind, placebo-controlled trial","volume":"62","author":"Strik","year":"2000","journal-title":"Psychosom Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib68","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/S0002-8703(99)70369-8","article-title":"An open-label preliminary trial of sertraline for treatment of major depression after acute myocardial infarction (the SADHART trial). Sertraline Anti-Depressant Heart Attack Trial","volume":"137","author":"Shapiro","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2005.01.041_bib69","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1001\/jama.288.6.701","article-title":"Sertraline treatment of major depression in patients with acute MI or unstable angina","volume":"288","author":"Glassman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.01.041_bib70","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1001\/jama.289.23.3106","article-title":"Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) Randomized Trial","volume":"289","author":"Berkman","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2005.01.041_bib71","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0278-5846(00)00168-8","article-title":"Clinical and treatment response characteristics of late-life depression associated with vascular disease: a pooled analysis of two multicenter trials with sertraline","volume":"25","author":"Krishnan","year":"2001","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib72","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1161\/hc4101.097519","article-title":"Selective serotonin reuptake inhibitors and myocardial infarction","volume":"104","author":"Sauer","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.01.041_bib73","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1067\/mhj.2001.116766","article-title":"Effect of sertraline on the recovery rate of cardiac autonomic function in depressed patients after acute myocardial infarction","volume":"142","author":"McFarlane","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2005.01.041_bib74","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S0006-3223(02)01394-X","article-title":"Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on long-term heart rate variability measures","volume":"52","author":"Yeragani","year":"2002","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib75","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000066390","article-title":"Major depression with ischemic heart disease: effects of paroxetine and nortriptyline on measures of nonlinearity and chaos of heart rate","volume":"46","author":"Yeragani","year":"2002","journal-title":"Neuropsychobiology"},{"key":"10.1016\/j.ahj.2005.01.041_bib76","first-page":"678","article-title":"The effects of psychopharmacological therapy on heart rate variation","volume":"66","author":"Rechlin","year":"1995","journal-title":"Nervenarzt"},{"key":"10.1016\/j.ahj.2005.01.041_bib77","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1464-5491.1992.tb01754.x","article-title":"Assessment of cardiovascular autonomic function: age-related normal ranges and reproducibility of spectral analysis, vector analysis, and standard tests of heart rate variation and blood pressure responses","volume":"9","author":"Ziegler","year":"1992","journal-title":"Diabet Med"},{"key":"10.1016\/j.ahj.2005.01.041_bib78","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/1056-8727(92)90049-Q","article-title":"The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group","volume":"6","author":"Ziegler","year":"1992","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.ahj.2005.01.041_bib79","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/070674379804300209","article-title":"Autonomic correlates of antidepressant treatment using heart-rate variability analysis","volume":"43","author":"Khaykin","year":"1998","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib80","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1161\/01.CIR.89.5.1992","article-title":"Prospective study of phobic anxiety and risk of coronary heart disease in men","volume":"89","author":"Kawachi","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.01.041_bib81","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1161\/01.CIR.90.5.2225","article-title":"Symptoms of anxiety and risk of coronary heart disease. The Normative Aging Study","volume":"90","author":"Kawachi","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2005.01.041_bib82","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1097\/00004714-199710000-00006","article-title":"Paroxetine increases heart rate variability in panic disorder","volume":"17","author":"Tucker","year":"1997","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.ahj.2005.01.041_bib83","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1002\/(SICI)1520-6394(2000)11:3<126::AID-DA7>3.0.CO;2-1","article-title":"Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder","volume":"11","author":"Yeragani","year":"2000","journal-title":"Depress Anxiety"},{"key":"10.1016\/j.ahj.2005.01.041_bib84","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00004714-200004000-00004","article-title":"Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment","volume":"20","author":"Pollock","year":"2000","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.ahj.2005.01.041_bib85","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1001\/archpsyc.57.9.875","article-title":"Platelet reactivity in depressed patients treated with paroxetine\u2014preliminary findings","volume":"57","author":"Musselman","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib86","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000085163.21752.0A","article-title":"Platelet\/endothelial biomarkers in depressed patients treated with the selective serotonin reuptake inhibitor sertraline after acute coronary events: the Sertraline Antidepressant Heart Attack Randomized Trial (SADHART) Platelet substudy","volume":"108","author":"Serebruany","year":"2003","journal-title":"Circulation"},{"issue":"Suppl 5","key":"10.1016\/j.ahj.2005.01.041_bib87","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/00004850-199809005-00009","article-title":"Differences in interactions of SSRIs","volume":"13","author":"Brosen","year":"1998","journal-title":"Int Clin Psychopharmacol"},{"issue":"Suppl 15","key":"10.1016\/j.ahj.2005.01.041_bib88","first-page":"19","article-title":"Drug interactions with newer antidepressants: role of human cytochromes P450","volume":"59","author":"Greenblatt","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib89","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/01.HDX.0000061695.97215.64","article-title":"Cardiovascular effects of selective serotonin reuptake inhibitors and other novel antidepressants","volume":"5","author":"Khawaja","year":"2003","journal-title":"Heart Dis"},{"key":"10.1016\/j.ahj.2005.01.041_bib90","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1176\/ajp.153.3.311","article-title":"Newer antidepressants and the cytochrome P450 system","volume":"153","author":"Nemeroff","year":"1996","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib91","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1176\/ajp.148.4.512","article-title":"Cardiovascular effects of bupropion in depressed patients with heart disease","volume":"148","author":"Roose","year":"1991","journal-title":"Am J Psychiatry"},{"issue":"Suppl 7","key":"10.1016\/j.ahj.2005.01.041_bib92","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1097\/00005344-199001001-00004","article-title":"Cardiovascular effects of serotonin agonists and antagonists","volume":"15","author":"Saxena","year":"1990","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.ahj.2005.01.041_bib93","first-page":"574","article-title":"Cardiovascular safety in depressed patients: focus on venlafaxine","volume":"56","author":"Feighner","year":"1995","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib94","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/026988119901300212","article-title":"An acute ischaemic event associated with the use of venlafaxine: a case report and proposed pathophysiological mechanisms","volume":"13","author":"Reznik","year":"1999","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.ahj.2005.01.041_bib95","doi-asserted-by":"crossref","first-page":"875","DOI":"10.4088\/JCP.v64n0804","article-title":"Probing the safety of medications in the frail elderly: evidence from a randomized clinical trial of sertraline and venlafaxine in depressed nursing home residents","volume":"64","author":"Oslin","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib96","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1001\/archpsyc.57.5.503","article-title":"Evidence of the dual mechanisms of action of venlafaxine","volume":"57","author":"Harvey","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.ahj.2005.01.041_bib97","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0306-4530(01)00002-6","article-title":"Short-term sertraline treatment suppresses sympathetic nervous system activity in healthy human subjects","volume":"26","author":"Shores","year":"2001","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.ahj.2005.01.041_bib98","doi-asserted-by":"crossref","first-page":"S274","DOI":"10.1016\/S0924-977X(03)91943-2","article-title":"Effects of paroxetine and venlafaxine-XR on heart rate variability in depression","volume":"13","author":"Watkins","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"issue":"Suppl 8","key":"10.1016\/j.ahj.2005.01.041_bib99","first-page":"24","article-title":"Consensus statement on depression, anxiety, and cardiovascular disease","volume":"62","author":"Ballenger","year":"2001","journal-title":"J Clin Psychiatry"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305001122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870305001122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:15:56Z","timestamp":1757567756000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870305001122"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":99,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S0002870305001122"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2005.01.041","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant therapy in patients with ischemic heart disease","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2005.01.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}